Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases

Authors:

Abstract
No abstract available
Funding Information
  • Suzhou Municipal Science and Technology Bureau
  • Ministry of Education of the People's Republic of China
  • Hainan Provincial Health and Family Planning Commission